Clexio Biosciences
PrivateCompany Overview
Clexio Biosciences operates in Healthcare & Life Sciences and is based in Israel. It was founded in 2018.
Clexio Biosciences is a clinical-stage pharmaceutical company that develops novel drugs and drug-device combinations for the treatment of neurological and psychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clexio Biosciences Comparables
Compare Clexio Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evecxia Therapeutics | 82% | |
| MapLight Therapeutics | 76% | |
| Addex Therapeutics | 74% |
For institutional investors. Book with your work email.
Clexio Biosciences Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 49% MoM, reaching 3.6K.
- Jan 5, 2026
Monthly visitors increased 65% MoM.
For institutional investors. Book with your work email.
Clexio Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clexio Biosciences's valuation, stock price, and market status.
Is Clexio Biosciences a public or private company?
Clexio Biosciences is a private company.
What is the current stock price of Clexio Biosciences?
Clexio Biosciences is a private company, so its shares have no public market price. Caplight tracks Clexio Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clexio Biosciences worth (valuation)?
Valuation information for Clexio Biosciences is not publicly available.
Can I buy Clexio Biosciences stock?
Clexio Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clexio Biosciences's last funding round?
Funding round information for Clexio Biosciences is not publicly available.
Who are the main investors in Clexio Biosciences?
Investor information for Clexio Biosciences is not publicly disclosed.
Will Clexio Biosciences IPO soon?
No public IPO plans have been announced for Clexio Biosciences.
How can I track Clexio Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Clexio Biosciences's shares on secondary markets.